Drug
Ralinepag
Ralinepag is a pharmaceutical drug with 5 clinical trials. Historical success rate of 75.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_3
3
60%
Ph phase_1
1
20%
Ph phase_2
1
20%
Phase Distribution
1
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
3(60.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 33 (60.0%)
Trials by Status
terminated120%
completed360%
enrolling_by_invitation120%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_3
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
NCT03626688
enrolling_by_invitationphase_3
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186
completedphase_1
A Study of Ralinepag in Healthy Chinese Adult Subjects
NCT04613999
terminatedphase_3
A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH
NCT04084678
completedphase_2
Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension
NCT02279745
Clinical Trials (5)
Showing 5 of 5 trials
NCT03626688Phase 3
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
NCT03683186Phase 3
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT04613999Phase 1
A Study of Ralinepag in Healthy Chinese Adult Subjects
NCT04084678Phase 3
A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH
NCT02279745Phase 2
Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5